{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0008170,73,MONDO:0008170,192,0]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0008170","source":"MONDO:0008170|ovarian cancer","targets":["NCT00190697|A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment|COMPLETED|PHASE4|INTERVENTIONAL","NCT00277160|A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00727961|A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00740116|Tranexamic Acid in Surgery of Advanced Ovarian Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT00817479|Tumor Gene Expression in Women With Ovarian Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT01432015|Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting|COMPLETED|PHASE4|INTERVENTIONAL","NCT01706120|Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01932125|An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT01953107|Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.|COMPLETED|PHASE4|INTERVENTIONAL","NCT02035345|Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment|TERMINATED|PHASE4|INTERVENTIONAL","NCT02243059|Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT03164980|QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer|TERMINATED|PHASE4|INTERVENTIONAL","NCT03384511|The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.|COMPLETED|PHASE4|INTERVENTIONAL","NCT03543462|Diaphragmatic Resection And Gynecological Ovarian Neoplasm|COMPLETED|PHASE4|INTERVENTIONAL","NCT03752216|NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.|COMPLETED|PHASE4|INTERVENTIONAL","NCT03858166|Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer|TERMINATED|PHASE4|INTERVENTIONAL","NCT04024254|A Study of Serum Folate Levels in Patients Treated With Olaparib|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT04330040|Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT04352439|Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT05187208|PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05606692|Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)|RECRUITING|PHASE4|INTERVENTIONAL","NCT05926336|The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action|RECRUITING|PHASE4|INTERVENTIONAL","NCT06412120|Study Evaluating Safety, Tolerability, and Metabolism of Niraparib|RECRUITING|PHASE4|INTERVENTIONAL","NCT06871787|Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT06887933|A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT00001806|Methods in Education for Breast Cancer Genetics|COMPLETED|PHASE3|INTERVENTIONAL","NCT00002477|Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00002568|Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00002641|Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00002717|Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00002764|Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00002819|Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT00002894|Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00002895|Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003120|S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003214|Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003322|Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003636|Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003644|Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003695|Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003880|Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT00003998|Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00004115|Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00004166|Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00004921|High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery|COMPLETED|PHASE3|INTERVENTIONAL","NCT00004934|Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00005590|Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00006356|Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT00006453|Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00006454|Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00011986|Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00028743|Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00033605|Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00043082|S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00045461|Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT00050375|Clinical Trial for Ovarian Cancer (OvaRex®)|TERMINATED|PHASE3|INTERVENTIONAL","NCT00052468|Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00057720|TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00075712|Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00098878|Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00102375|Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00102414|Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00102973|TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00113607|An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00170690|Preference Study With Elderly Patients Recurrent Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00189553|Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse|COMPLETED|PHASE3|INTERVENTIONAL","NCT00191607|A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.|COMPLETED|PHASE3|INTERVENTIONAL","NCT00191646|An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00243685|Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00245050|Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00262847|Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00262990|Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00263822|Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00270166|The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00274950|Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00312988|Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00324324|Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant|TERMINATED|PHASE3|INTERVENTIONAL","NCT00326456|MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00327444|Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00350948|Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT00382811|OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00418574|Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT00426257|Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00434642|A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00437307|Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse|COMPLETED|PHASE3|INTERVENTIONAL","NCT00443196|Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00477282|Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00483782|Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00532194|An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00533299|Hydralazine Valproate for Ovarian Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00653952|CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy|TERMINATED|PHASE3|INTERVENTIONAL","NCT00657878|Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00660842|Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00693342|Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT00716976|Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00726635|The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00782145|A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families|COMPLETED|PHASE3|INTERVENTIONAL","NCT00849667|Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse|TERMINATED|PHASE3|INTERVENTIONAL","NCT00866697|Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00976911|AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer|COMPLETED|PHASE3|INTERVENTIONAL"]}]}